Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19

BACKGROUND: Patients recovering from COVID-19 may need vaccination against SARS-CoV-2 because acquired immunity from primary infection may wane, given the emergence of new SARS-CoV-2 variants. Understanding the trends of anti-spike IgG and neutralizing antibody titers in patients recovering from COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wang-Da, Wang, Jann-Tay, Chao, Tai-Ling, Ieong, Si-Man, Tsai, Ya-Min, Kuo, Po-Hsien, Tsai, Ming-Jui, Chen, Yi-Jie, Li, Guei-Chi, Ho, Shu-Yuan, Chen, Hui-Hou, Huang, Yu-Shan, Hung, Chien-Ching, Chen, Yee-Chun, Chang, Sui-Yuan, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Formosan Medical Association, Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705194/
https://www.ncbi.nlm.nih.gov/pubmed/36496300
http://dx.doi.org/10.1016/j.jfma.2022.11.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705194/
https://www.ncbi.nlm.nih.gov/pubmed/36496300
http://dx.doi.org/10.1016/j.jfma.2022.11.015

Ejemplares similares